Prevalence of overweight and prediabetes in men receiving systemic therapies for metastatic prostate cancer.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalJournal of Clinical Oncology
DOIs
Publication statusPublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medicine
  • Prostate cancer
  • Prediabetes
  • Overweight
  • Androgen deprivation therapy
  • Internal medicine
  • Enzalutamide
  • Type 2 diabetes
  • Cancer
  • Population
  • Oncology
  • Diabetes mellitus
  • Body mass index
  • Endocrinology
  • Androgen receptor
  • Environmental health

Cite this